Skip to main content

Year: 2022

Thor Equities Group Continues Industrial Expansion in Georgia

New York, NY, Nov. 09, 2022 (GLOBE NEWSWIRE) — Thor Equities Group, a global leader in urban real estate development, leasing and management, is pleased to announce the acquisition of a 40-acre parcel in Adairsville, Georgia. Adjacent to Thor’s development of the Gordon Logistics Center, a 1,038,000 square foot state-of-the-art facility, Thor has the potential to develop an additional 450,000 square foot Class A industrial building on the new, bordering tract. This latest acquisition represents the fifth industrial investment in the past few months following acquisitions in Northern New Jersey, Los Angeles, Savannah, and Tampa.    At the intersection of Highway 41 and Trimble Hollow Road SE in Gordon County, 2334 Trimble Hollow Road offers a valuable location on the I-75N corridor with access to a large labor pool. The property...

Continue reading

VERB to Host Third Quarter 2022 Earnings Call on Monday, November 14, 2022, at 5:30 p.m. ET

NEWPORT BEACH, Calif. and SALT LAKE CITY, Nov. 09, 2022 (GLOBE NEWSWIRE) — Verb Technology Company, Inc. (NASDAQ: VERB) (“VERB” or the “Company”), the leader in interactive video-based sales enablement applications, including shoppable livestream, today announced that it will host a conference call to discuss its financial results for the third quarter ended September 30, 2022 on Monday, November 14, 2022, at 5:30 p.m. Eastern time (2:30 p.m. Pacific time). Financial results will be issued in a press release prior to the call. The Company’s CEO is expected to address the most important questions investors have about the Company. VERB CEO Rory J. Cutaia and CFO Salman Khan will host the conference call, followed by a question-and-answer period. VERB Q3 2022 Earnings CallDate: Monday, November 14, 2022Time: 5:30 p.m. Eastern time...

Continue reading

Dentsply Sirona to Host Third Quarter Conference Call on November 14th

CHARLOTTE, N.C., Nov. 09, 2022 (GLOBE NEWSWIRE) — DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY) today announced that the Company will be hosting an investor conference call and live webcast on Monday, November 14, 2022, at 8:30 am ET to review its third quarter financial results. A presentation related to the call will be available on the Investors section of the Company’s website at https://investor.dentsplysirona.com. Conference Call / Webcast Information  A live webcast will be available on the Investors section of the Company’s website at https://investor.dentsplysirona.com. For those planning to participate on the call, please register at https://dpregister.com/sreg/10173404/f51ed93790. A webcast replay of the conference call will be available on the Investors section of the Company’s website following the call. About...

Continue reading

McPhy Energy : Monthly report relating to the total number of voting rights and outstanding shares

Translation for information purposes only Monthly informationrelating to the total number of voting rights and outstanding shares In accordance with articles L. 233-8-II of the French Commercial Code and 223-16 of the Autorité des Marchés Financiers General Regulation Reporting company:Corporate name: McPhy Energy Public Limited company (société anonyme) with Board of Directors Registered office: 79 rue Général Mangin, 38100 Grenoble Registered under number 502 205 917 R.C.S. Grenoble Euronext Paris Compartment B (ISIN code: FR0011742329 – MCPHY)Date Total number ofoutstanding shares Total number of voting rights*Gross Net31.10.2022 27,959,095 29,274,530 29,207,246* Total number of voting rights (i) “gross” calculated on the basis of all the shares to which voting rights are attached,...

Continue reading

NowVertical Group Receives 2022 HIRE Vets Medallion Award from the U.S. Department of Labor

TORONTO, Nov. 09, 2022 (GLOBE NEWSWIRE) — NowVertical Group Inc. (TSX-V: NOW) (“NOW” or the “Company”), the vertical intelligence (“VI”) software and solutions company, is pleased to announce that Allegient Defense, NOW’s Government Solutions team, was recognized by U.S. Secretary of Labor Martin J. Walsh as one of the 835 recipients of the 2022 HIRE Vets Medallion Award during a virtual award ceremony earlier today presented by U.S. Department of Labor. NOW’s Government Solutions team, Allegient Defense, earned the gold award from the Honoring Investments in Recruiting and Employing American Military Veterans Act (HIRE Vets Act) Medallion Program. The program is the only federal award program that recognizes employers who successfully recruit, hire, and retain veterans. “From NOW’s earliest days, we’ve known that Government solutions...

Continue reading

HII Wins U.S. Air Force $70 Million Technical Analysis and Research Contract to Support AI/ML and Cyber Modernization Priorities

MCLEAN, Va., Nov. 09, 2022 (GLOBE NEWSWIRE) — HII’s (NYSE: HII) Mission Technologies division was awarded a $70 million task order contract by the U.S. Air Force to perform technical analysis and recommend enhancements for the Air Force Research Laboratory (AFRL). HII’s research and analysis will be leveraged by the Air Force to support the Department of Defense’s artificial intelligence/machine learning and cyber modernization priorities. “We look forward to continuing to support AFRL’s IT systems, enterprise modernization and digital transformation efforts,” said Grant Hagen, president of Mission Technologies’ Cyber, Electronic Warfare & Space business. “The HII team understands the challenges facing the Air Force and has the proven technical expertise and vision to help facilitate alignment across its IT enterprise.” HII...

Continue reading

Safe announces the convocation of an extraordinary general meeting of the Company to be held on December 16, 2022

Convocation of an extraordinary general meeting called to vote on the delegation of authority to the Company’s Board of Directors to proceed with (i) the reverse stock split of the Company’s shares by the allocation of one (1) new ordinary share with a par value of twelve (12) euros each against one thousand two hundred (1. 200) old ordinary shares, (ii) a reduction in the Company’s share capital due to losses within the limit of 10% more or less of an amount of € 5,000,000 and (iii) an increase in the share capital by issuing shares with cancellation of the preferential subscription right in favor of categories of personsEragny-sur-Oise, France, November 9th, 2022, 6:30 CET – Safe (FR0013467123 – ALSAF), a company specializing in the design, manufacturing, and marketing of single-use technologies for spinal surgeries,...

Continue reading

Áhersla á Grunnþjónustu og Uppbyggingu Innviða í   Mosfellsbæ Árið 2023

9. nóvember 2022Fjárhagsáætlun Mosfellsbæjar fyrir árið 2023 og næstu þrjú ár þar á eftir var lögð fram til fyrri umræðu í bæjarstjórn í dag,  þann 9. nóvember.Nýjum lóðum verður úthlutað í 5. áfanga uppbyggingar í Helgafellslandi. Fjárfest verður fyrir rúma fjóra milljarða  til að byggja upp innviði Áformað er að A- og B-hluti verði rekinn með 548 m.kr. afgangi á næsta ári. Veltufé frá rekstri verður jákvætt um 2.151 m.kr. eða 11% af heildartekjum. Álagningarhlutfall fasteignagjalda lækkar til að koma til móts við hækkun fasteignamats. Skuldir sem hlutfall af tekjum munu lækka og skuldaviðmiðið verður 89,9%.  Álagningarhlutfall útsvars verður 14,52% en útsvar er um 52% af heildartekjum sveitarfélagsins. Hækkun á gjaldskrám verður hófleg og til samræmis við breytingar á verðlagi. Íbúar eru um 13.300 og er ætluð fjölgun um 2,5% á...

Continue reading

Genmab Announces Financial Results for the First Nine Months of 2022

November 9, 2022 Copenhagen, Denmark; Interim Report for the First Nine Months Ended September 30, 2022 HighlightsGenmab revenue increased 60% compared to the first nine months of 2021, to DKK 9,368 million Genmab improves its 2022 financial guidance“During the first nine months of the year we continued to build on Genmab’s consistent track record of success. We have strengthened our pipeline, our team and our financial foundation is even more robust. We are pleased with the recent U.S. and European regulatory submissions for epcoritamab. These submissions are an important step in potentially bringing epcoritamab to people living with certain hematologic malignancies who are in need of a new treatment option,” said Jan van de Winkel, Ph.D., Chief Executive Officer of Genmab. Financial Performance First Nine Months of 2022Net sales...

Continue reading

Ceapro Inc. Reports 2022 Third Quarter and Nine-Month Financial Results and Operational Highlights

– R&D activities focused on the production of Avenanthramides pills for clinical trials and for scale-up of the PGX Technology – Q3 2022 sales of $3,845,000 vs $4,523,000 in Q3 2021; YTD sales increase 14% vs 2021 – $15,517,000 vs $13,633,000 – Income before tax of $1,128,000 in Q3 2022 vs $875,000 in Q3 2021; YTD Income before tax increased 186% vs 2021 – $5,919,000 vs $2,067,000 EDMONTON, Alberta, Nov. 09, 2022 (GLOBE NEWSWIRE) —  Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) (“Ceapro” or the “Company”), a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries, today announced financial results and operational highlights for the third quarter and nine months ended September 30, 2022. “Thanks to the hard work and commitment of...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.